Follow the Lotus Eye Hospital and Institute Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Lotus Eye Hospital and Institute Limited has recorded 8 public disclosures. Market capitalisation: €2.3bn. The latest transaction was filed on 6 July 2024 (Sale). Among the most active insiders: S Rajkumar. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
€40,170
2 ops.
Buy Volume
€2m
4 ops.
Sell Volume
8Σ signal
Buys €40,170€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,694 of 26,211 companies
28.6
score / 100
Value
19
Quality
38
FCF yld-4.1%
Earn yld0.0%
EV/EBITDA57.5x
ROE0.1%
Gross mgn49%
Net mgn0.1%
Debt/EBITDA3.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.